Chemoreception pp 187-192 | Cite as

Amyloid Peptide-Mediated Hypoxic Regulation of Ca2+ Channels in PC12 Cells

  • Chris Peers
  • Kim N. Green
  • John P. Boyle
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 536)


The incidence of dementias such as Alzheimer’s Disease (AD) is dramatically increased in patients who have previously suffered prolonged hypoxic or ischemic episodes. Such episodes commonly arise as a consequence of cardiovascular dysfunctions such as stroke (Tatemichi et al. 1994; Kokmen et al. 1996; Moroney et al. 1996). This clear link between hypoxic/ischemic episodes and increased incidence of AD strongly suggests that reduction in local O2 levels may be capable of precipitating this increasingly widespread disease.


PC12 Cell Chronic Hypoxia Amyloid Peptide Ischemic Episode Influx Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arispe, N., Pollard, H.B. and Rojas, E., 1996, Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc.NatiAcad.ScLUSA 93: 1710–1715.CrossRefGoogle Scholar
  2. Behl, C., Davis, J.B., Lesley, R. and Schubert, D., 1994, Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817–827.PubMedCrossRefGoogle Scholar
  3. Fraser, S.P., Suh, Y.-H. and Djamgoz, M.B.A., 1997, Ionic effects of the Alzheimer’s disease beta-amyloid precursor protein and its metabolic fragments Trends Neurosci. 20: 67–72.PubMedCrossRefGoogle Scholar
  4. Glenner, G.G. and Wong, C.W., 1984, Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem.Biophys. Res. Comm. 120: 885–890.PubMedCrossRefGoogle Scholar
  5. Green, K.N. and Peers, C, 2001, Amyloid peptides mediate hypoxic augmentation of Ca2+ channels. J. Neurochem. 11: 953–956.CrossRefGoogle Scholar
  6. Jendroska, K., Hoffmann, O.M. and Patt, S., 1997, Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia Ann.N. Y.Acad. Sci. 826: 401–405.PubMedCrossRefGoogle Scholar
  7. Kawahara, M., Arispe, N., Kuroda, Y. and Rojas, E., 1997, Alzheimer’s disease amyloid beta-protein forms Zn2+-sensitive, cation selective channels across excised membrane patches from hypothalamic neurons. Biophys. J. 73: 67–75.PubMedCrossRefGoogle Scholar
  8. Kogure, K. and Kato, H., 1993, Altered gene expression in cerebral ischemia Stroke 24: 2121–2127.PubMedCrossRefGoogle Scholar
  9. Kokmen, E., Whisnant, J.P., OTallon, W.M., Chu, C.P. and Beard, C.M., 1996, Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46: 1960–1984.PubMedCrossRefGoogle Scholar
  10. Koistinaho, J., Pyykonen, I., Keinanen, R. and Hokfelt, T., 1996, Expression of beta-amyloid precursor protein mRNAs following transient focal ischemia Neuroreport 1: 2727–2731.CrossRefGoogle Scholar
  11. Masters, C.L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R.N. and Beyreuther, K., 1985, Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4:2757–2763.PubMedGoogle Scholar
  12. Mattson, M.P., 1997, Cellular actions of ß-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev. 11: 1081–1132.Google Scholar
  13. Moroney, J.T., Bagiella, E., Desmond, D.W., Paik, M.C., Stern, Y. and Tatemichi, T.K., 1996, Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 27, 1283–1289.PubMedCrossRefGoogle Scholar
  14. Rhee, S.K., Quist, A.P. and Lai, R., 1998, Amyloid ß protein (1–42) forms calcium-permeable, Zn2+-sensitive channel. J. Biol. Chem. 273: 1–42.PubMedCrossRefGoogle Scholar
  15. Schubert, D., Behl, C, Lesley, R., Brack, A., Dargusch, R., Sagara, Y. and Kimura, H., 1995, Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92: 1989–1993.PubMedCrossRefGoogle Scholar
  16. Selkoe, D.J., 2001, Alzheimer’s disease: genes, proteins and therapy. Physiol. Rev. 81: 741–766.Google Scholar
  17. Tatemichi, T.K., Paik, M., Bagiella, E., Desmond, D.W., Stern, Y., Sano, M. Hauser, W.A. and Mayeux, R., 1994, Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44: 1885–1891.PubMedCrossRefGoogle Scholar
  18. Taylor, S.C., Batten, T.F.C. and Peers, C, 1999, Hypoxic enhancement of quantal catecholamine secretion: evidence for the involvement of amyloid ß-peptides. J. Biol. Chem. 274:31217–31223.PubMedCrossRefGoogle Scholar
  19. Yokota, M., Saido, T.C., Tani, E., Yamaura, I. and Minami, N., 19%, Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia J. Cereb. Blood Flow Metab. 16: 1219–1223.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Chris Peers
    • 1
  • Kim N. Green
    • 1
  • John P. Boyle
    • 1
  1. 1.Institute for Cardiovascular Research, Worsley Medical and Dental BuildingUniversity of LeedsUK

Personalised recommendations